Leishmaniasis: Opciones terapéuticas en la población pediátrica / Leishmaniasis: Therapeutic options in the pediatric population
Med. leg. Costa Rica
;
35(1): 52-64, ene.-mar. 2018.
Article
in Spanish
| LILACS
| ID: biblio-894338
RESUMEN
Resumen La leishmaniasis es una enfermedad parasitaria crónica endémica en muchas partes del mundo. La variabilidad de cepas, su clínica y respuesta a tratamiento ha hecho que se clasifique en dos grandes grupos la leishmaniasis del Nuevo Mundo y la del Viejo Mundo. Según esto, varían las recomendaciones respecto a manejo y seguimiento. En esta revisión se hace énfasis a la leishmaniasis de nuestro medio, revisando opciones terapéuticas y posibilidades principalmente en la población pediátrica.
ABSTRACT
Abstract Leishmaniasis is a chronic parasitic disease endemic in many parts of the world. The variability of strains, their clinic and response to treatment has led to their classification into two major groups New World leishmaniasis and Old World leishmaniasis. According to this, the recommendations regarding management and follow-up vary. In this review, emphasis is placed on leishmaniasis in our environment, reviewing therapeutic options and possibilities mainly in the pediatric population.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Parasitic Diseases
/
Pediatrics
/
Pentamidine
/
Paromomycin
/
Leishmaniasis
/
Leishmaniasis, Mucocutaneous
/
Amphotericin B
/
Leishmaniasis, Cutaneous
/
Costa Rica
/
Meglumine Antimoniate
Type of study:
Practice guideline
Limits:
Humans
Country/Region as subject:
Central America
/
Costa Rica
Language:
Spanish
Journal:
Med. leg. Costa Rica
Journal subject:
Jurisprudence
Year:
2018
Type:
Article
Affiliation country:
Costa Rica
Institution/Affiliation country:
Hospital Nacional de Niños/CR
/
UCR/CR
Similar
MEDLINE
...
LILACS
LIS